View in EDS PDF Full Text

The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.

Saved in:
Bibliographic Details
Title: The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Authors: Diamantopoulos, Panagiotis T.1 (AUTHOR) pandiamantopoulos@gmail.com, Symeonidis, Argiris2 (AUTHOR), Pappa, Vasiliki3 (AUTHOR), Kotsianidis, Ioannis4 (AUTHOR), Galanopoulos, Athanasios5 (AUTHOR), Pontikoglou, Charalampos6 (AUTHOR), Anagnostopoulos, Achilles7 (AUTHOR), Vassilopoulos, George8 (AUTHOR), Zikos, Panagiotis9 (AUTHOR), Hatzimichael, Eleftheria10 (AUTHOR), Papaioannou, Maria11 (AUTHOR), Megalakaki, Aekaterini12 (AUTHOR), Repousis, Panagiotis12 (AUTHOR), Kotsopoulou, Maria12 (AUTHOR), Dimou, Maria13 (AUTHOR), Solomou, Elena2 (AUTHOR), Dryllis, Georgios1 (AUTHOR), Tsokanas, Dimitrios5 (AUTHOR), Papoutselis, Menelaos‐Konstantinos4 (AUTHOR), Papageorgiou, Sotirios3 (AUTHOR)
Source: British Journal of Haematology. Mar2021, Vol. 192 Issue 6, p978-987. 10p.
Database: Academic Search Ultimate
Description
ISSN:00071048
DOI:10.1111/bjh.17062